StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Systematix Shares & Stock

BUYRainbow Childrens Medicare Limited
Rainbow Childrens Medicare share price target & all analyst calls

bySystematix Shares & StockHorizon: NA (inferred 1 year)7 Jul 2026via Economic Times New Stock Recos

Entry₹1,442Inferred
Target₹1,598
Total upside +10.82% (call closed)
Stop lossNot given
Exit₹1,5985 Aug 2026, 12:08 pm
Target hit+10.82%0.00%upside left
Follow Systematix Shares & Stock for new callsGet alertsWatch RAINBOW for new buy/sell callsGet alertsSee 5 active Long-term calls on RAINBOWSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Aug 2026
8 supporting3 neutral1 opposing
Supports the BUY call (8)

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·4 Aug · yesterday

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·3 Aug · 2d ago

Rainbow Children's Medicare Ltd announced its financial results for the quarter ended June 30, 2026, reporting a robust performance with revenue growth of approximately 33% YoY. The company also highl

BSE · Company Update·30 Jul · 5d ago

(opens in new tab)

Rainbow Children's Medicare Q1 profit rises 13% as revenue jumps 33%

NewsCnbc-Tv18·30 Jul · 5d ago

(opens in new tab)

Rainbow Children's Medicare Ltd is acquiring a 64% partnership interest in Super Prime Medical Care LLP for ₹19.84 Cr, which operates a 70-bed children's hospital in Nellore, Andhra Pradesh. This acqu

BSE · Company Update·29 Jul · 6d ago

(opens in new tab)
Neutral / worth noting (3)

Rainbow Childrens Medicare Limited announced its un-audited financial results for the quarter ended June 30, 2026. The company reported revenue growth of ~33% YoY, driven by strong performance across

NSE · Press Release·30 Jul · 5d ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rainbow Childrens Medicare

All analyst calls on Rainbow Childrens Medicare

More from Systematix Shares & Stock

Every call and its outcome